ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag european medicines agency immunology neuroscience genetics genomics

Top 10 Innovations 2021
2021 Top 10 Innovations
The Scientist | Dec 1, 2021 | 10+ min read
The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.
Top 10 Innovations 2013
The Scientist | Dec 1, 2013 | 10+ min read
The Scientist’s annual competition uncovered a bonanza of interesting technologies that made their way onto the market and into labs this year.
herpes herpesvirus ms multiple sclerosis
Type of Herpes Virus Tied to Multiple Sclerosis
Katarina Zimmer | Jan 10, 2020 | 5 min read
A study of 16,000 people suggests that human herpesvirus 6A is a risk factor for developing multiple sclerosis, reinvigorating a neglected hypothesis that the virus could be involved in triggering the disease.
Going Viral
Breeann Kirby and Jeremy J. Barr | Sep 1, 2013 | 10+ min read
From therapeutics to gene transfer, bacteriophages offer a sustainable and powerful method of controlling microbes.
Week in Review: February 3–7
Tracy Vence | Feb 6, 2014 | 3 min read
Federal stem cell regulations vary; Salmonella exploit host immune system; microglia help maintain synaptic connections; prosthesis re-creates feeling of touch
Genetics-Based Testing Could Create A Biologic Underclass
Dorothy Nelkin | Nov 26, 1989 | 9 min read
[Editor’s note: Sophisticated biological tests that can uncover latent problems or predict future diseases have been developed over the past few years. Such tests have important clinical applications, but they also have found their way into nonclinical contexts in which they provide unprecedented threats to our traditional concepts of privacy and personal autonomy. So say Dorothy Nelkin and Laurence Tancredi, coauthors of a new book, Dangerous Diagnostics: The Social Power of Biological I
Green Gene Advocates Await Climate Change
Martina Habeck | Sep 29, 2002 | 5 min read
Graphic: Erica P. Johnson German plant biotechnology companies, frustrated by a European moratorium and lacking political and public support in their home country, struggle to sustain their re-search. Many still hope that genetically modified (GM) plant products will eventually find their way to the market. Some officials even believe that green gene technology, as plant genetics are sometimes called, could become a cornerstone in the recovery of the eastern German economy. Basic academic res
Notebook
The Scientist Staff | Feb 15, 1998 | 8 min read
POSITIVE SIDE EFFECT Proposed legislation designed to ban genetic discrimination may boost participation in clinical trials, says Kathy L. Hudson, assistant director for policy coordination at the National Human Genome Research Institute. Vice President Al Gore issued guidelines for genetic discrimination legislation in a report entitled "Genetic Information and the Workplace" January 20 at the National Academy of Sciences. The legislation, if enacted, would bar employers from using genetic mak
Mental Map
Abdul-Kareem Ahmed | Nov 13, 2013 | 5 min read
From determining structures to figuring out functions, brain-mapping scientists are applying new technologies to understand the hub of the central nervous system.
Bioterrorism Research: New Money, New Anxieties
John Dudley Miller | Apr 6, 2003 | 8 min read
Ned Shaw US scientists have reason to feel both heady and scared. The federal government recently released unprecedented billions of dollars to fund bioterrorism research. Yet, the merits of this sudden shift in focus are being debated, and some worry that the money will be squandered or wasted. "I have been really very upset by the focus on bioterrorism," says Stanley Falkow, professor of microbiology and immunology and of medicine at Stanford University. "Everybody's talking about it, but th

Run a Search

ADVERTISEMENT